RxDoctor Payments Data

Steven Millen

Adult Health · Rockingham, NCNPI 1710182209

Payments from drug & device makers

$2,702in general payments, 2019–2025

Across 155 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$623
  • AbbVie$241
  • Novo Nordisk$217
  • Boehringer Ingelheim$194
  • AstraZeneca$187
  • GSK$141
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$2,57695%
  • Education$1275%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,702 in reported general payments places this provider in the 80th percentile of 614 adult health providers in North Carolina.

See all adult health providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin61$59,445
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$29,480
EliquisApixaban27$28,475
LinzessLinaclotide45$27,316
TrulicityDulaglutide17$26,167
FarxigaDapagliflozin Propanediol25$22,422
Repatha SureclickEvolocumab29$17,076
OzempicSemaglutide13$12,661
BelsomraSuvorexant27$11,295
GlyxambiEmpagliflozin/Linagliptin14$8,428
XareltoRivaroxaban13$8,251
SymbicortBudesonide/Formoterol Fumarate23$6,544
Albuterol Sulfate HfaAlbuterol Sulfate115$3,929
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine40$1,839
Omeprazole93$1,694

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Glyxambi$194$67,87375 claims
GSKTrelegy Ellipta$141$29,48030 claims
AstraZenecaFarxiga, Symbicort$187$28,96648 claims
PfizerEliquis$13$28,47527 claims
AbbVieLinzess$241$27,31645 claims
Lilly USA, LLCTrulicity$623$26,16717 claims
Novo NordiskOzempic$217$12,66113 claims
Johnson & JohnsonXarelto$103$8,25113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 614 adult health providers in North Carolina.

Other adult health in Rockingham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →